Cediranib maleateProduct ingredient for Cediranib
- Name
- Cediranib maleate
- Drug Entry
- Cediranib
The novel indole-ether quinazoline Cediranib is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of recombinant KDR tyrosine kinase in vitro. It is being developed clinically as a once-daily oral therapy for the treatment of cancer.
- Accession Number
- DBSALT002394
- Structure
Structure for Cediranib maleate (DBSALT002394)
- Synonyms
- AZD2171 Maleate / Cediranib maleat / Cediranib Maleate